Additionally, human Btk-deficient osteoclasts from X-linked agammaglobulinemia (XLA) patients are defective at bone resorption activity in vitro, potentially owing to dysregulation of actin cytoskeletal function [33]. This evidence concerns the gene BTK and Bruton-type agammaglobulinemia.